Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial

Astrid M. van Huizen*, Gayle E. van der Kraaij, Celine I. Busard, Wouter Ouwerkerk, Juul M.P.A. van den Reek, Stef P. Menting, Errol P. Prens, Theo Rispens, Annick de Vries, Elke M.G.J. de Jong, Jo Lambert, Martijn B.A. van Doorn, Phyllis I. Spuls

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
28 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science